01 August 2005
The use of recombinant human activated protein C (rhAPC) in the treatment of severe sepsis in immunosuppressed patients in the course of hematological diseases.
Anna Kunsdorf-Wnuk, Ewa Marzec-Lewenstein, Danuta Arct-Danielak, Ewa Musioł, Romuald Bohatyrewicz, Rafał BechtMed Sci Monit 2005; 11(8): CS49-55 :: ID: 202172
HTML version available soon